Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia-Reference-Cited by-同舟云学术

Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia

Published:2011-12-22 Issue:4 Volume:30 Page:190-193
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Ewalt Mark¹,Nandula Subhadra¹,Phillips Adrienne²,Alobeid Bachir¹,Murty Vundavalli V.¹,Mansukhani Mahesh M.¹,Bhagat Govind¹

Affiliation:

1. Department of Pathology and Cell Biology; Columbia University Medical Center and New York Presbyterian Hospital; New York; NY; USA

2. Department of Medicine, Division of Hematology and Oncology; Columbia University Medical Center and New York Presbyterian Hospital; New York; NY; USA

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference13 articles.

1. BRAF mutations in hairy-cell leukemia;Tiacci;N Engl J Med,2011

2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

3. BRAF mutations in non-Hodgkin's lymphoma;Lee;Br J Cancer,2003

4. Initial genome sequencing and analysis of multiple myeloma;Chapman;Nature,2011

5. High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies;Boyd;Br J Haematol,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Annexin 7 (ANXA7) as a tumor suppressor and a regulator of drug resistance in thyroid cancer;2024-05-20

2. Innovation in Oncology Drug Development;Journal of Oncology;2019-11-23

3. Genomics of Hairy Cell Leukemia;Journal of Clinical Oncology;2017-03-20

4. B-Cell Non-Hodgkin’s Lymphomas with a Small Cell to Intermediate Cell Phenotype: Special Phenotypes;Tumors and Tumor-Like Lesions of the Hepatobiliary Tract;2016-10-20

5. Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation;Oncology Letters;2016-10-18